A look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
María Proupín-Pérez, PhD
Advertisement
Articles by María Proupín-Pérez, PhD
This guidance document will offer information about RbM strategies.
Advertisement
Latest Updated Articles
RbM Guidance Document: Ten Burning Questions about Risk-Based Study ManagementPublished: January 13th 2015 | Updated:
The PUEKS Project: Process Innovation in Clinical Trial MonitoringPublished: August 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
AI in Action: Breaking Down Clinical Trial Bottlenecks
3
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
4
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
